Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide.
AUTOR(ES)
Godeau, B
RESUMO
A 49 year old white woman with systemic lupus erythematosus and bronchiolitis obliterans was treated with prednisone (1 mg/kg daily), which led to a transitory improvement in pulmonary status. Cyclophosphamide was then added--4 mg/kg daily intravenously for five days, then 2 mg/kg daily orally--and this was followed by a dramatic and prolonged improvement.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1004592Documentos Relacionados
- Bronchiolitis obliterans in systemic lupus erythematosus.
- Severe vasculitic neuropathy in systemic lupus erythematosus and response to cyclophosphamide.
- Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide.
- Cyclophosphamide in systemic lupus erythematosus.
- Systemic lupus erythematosus: new molecular targets
